![]() |
|
| Polio Vaccination |
Poliomyelitis better known in common parlour as 'Polio' is a
dreaded disease characterised by motor paralysis, and atrophy of skeletal muscles causing
permanent disability and deformity. in tropical countries like India, its is more
prevalent due in no small measure to the fact that the vaccine which is highly heat
sensitive and hence is always stored under refrigerated conditions, loses its potency the
moment it is exposed to ambient temperatures (say above 30oC). A break in
'cold-chain' follows resulting in irreversible damage to the vaccine and thereby reducing
its effectiveness. To offset this and to maintain its stability, a continuous world
wide search (under WHO's guidance) is on for a stabilised vaccine which will remain less
sensitive to temperature. HWB cognizant of R&D activities in this field of medical immunisation, has initiated a programmed through the Board of Research for Nuclear Science (BRNS) for developing a technologically feasible stabilised Oral Polio Vaccine (OPV) suspended in Heavy Water medium. Research activities conducted by HWB in collaboration with Entrovirus Research Centre, Mumbai of the Indian Council of Medical Research, G.O.I has shown very encouraging results. The inputs received so far show that Heavy Water at Concentration above 80% IP provides stabilising effect on OPV with the vaccine retaining its potency at 37oC for 7 days (WHO's norm for stabilised vaccine). Its is now proposed to establish this product through clinical trials for which statutory bodies will be approached. |
![]() |
| [ Historical
Background ] [ Board Members
] [ Organisation Chart ] [ Production Technology ] [ Plants at a Glance ] [ Safety Policy ] [ Projects Under Consideration ] [ Other Services ] [ HWBNewsletter ] [ Tenders ] [ FAQS ] [ Feedback ] [ Website Map ] [ Publications / Announcements ] |